+310.8%
AMKR vs GSK
+192.9%
+118.0%
-98.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +6.2% | -2.7% | +8.9% | +7.5% |
| 7D | +11.1% | -4.2% | +15.3% | +13.3% |
| 30D | -8.1% | -7.5% | -0.5% | -5.0% |
| 3M | -25.6% | -3.3% | -22.3% | -26.0% |
| 6M | +22.5% | -9.3% | +31.8% | +25.4% |
| YTD | +29.1% | +1.6% | +27.5% | +23.6% |
| 1Y | +105.7% | +25.5% | +80.2% | +74.9% |
| 3Y | +133.2% | +49.3% | +84.0% | +73.3% |
| 5Y | +98.5% | +46.7% | +51.9% | +43.6% |
| 10Y | +490.6% | +76.8% | +413.8% | +281.6% |
| All | +310.8% | +192.9% | +118.0% | +89.9% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling